Trial Profile
Cenderitide in patients with chronic heart failure
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 May 2011
Price :
$35
*
At a glance
- Drugs Cenderitide (Primary)
- Indications Chronic heart failure
- Focus Pharmacodynamics
- 16 May 2011 New trial record
- 05 Apr 2011 Results presented at the 60th Annual Scientific Session of the American College of Cardiology.